Immunex Message Board - Msg: 15549883

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brasco One who wrote (486)	3/22/2001 5:22:47 PM
From: LemurHouse	Read Replies (1) of 656

Its getting crushed after announcing bad news on Nuvance PhII trials, and that they are discontinuing trials using Enbrel for CHF. On the plus side, results of PHIII trials of Enbrel for Psoriatic Arthritis look good. Nuvance and CHF results are certainly bad news. But the main story with this company is Enbrel for RA, and the stock below $10 is a gift. I'll be buying as soon as it stops dropping -- but its dropping like a rock! CHF and Nuvance results are undeniably bad news. Company conf call at 15:30 eastern, by the way. AD

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next